Vaxart CEO Lo Steven Swells Equity Stake with Zero‑Price Stock‑Unit Grants Amid Anticipated Oral Vaccine Milestones
CEO Lo Steven’s bulk purchase of Vaxart shares signals long‑term confidence in the company’s oral vaccine platform, hinting at potential future upside.
4 minutes to read